Related Experiment Videos
Towards new mycobacterial vaccines
1Unité de Génétique Mycobactérienne, Institut Pasteur, Paris, France.
Developments in Biological Standardization
|January 1, 1994
Summary
Bacillus of Calmette and Guérin (BCG) effectively expresses foreign antigens like HIV Nef and beta-galactosidase, inducing immune responses. Transposon mutagenesis of Mycobacterium smegmatis was explored for novel tuberculosis vaccine development.
Area of Science:
- Microbiology
- Immunology
- Vaccinology
Background:
- The Bacillus of Calmette and Guérin (BCG) is a widely used vaccine vector.
- Foreign antigens can be expressed using BCG as a delivery system.
- Developing new tuberculosis vaccines is a critical global health priority.
Purpose of the Study:
- To evaluate BCG as a vector for expressing foreign antigens, including HIV Nef and beta-galactosidase.
- To investigate the immunogenicity of BCG-expressed antigens.
- To explore transposon mutagenesis for identifying novel tuberculosis vaccine candidates.
Main Methods:
- Cloning and expression of the HIV nef gene and beta-galactosidase gene in BCG.
- Immunization of mice with recombinant BCG strains.
- Assessment of cellular and antibody immune responses.
- Construction of Mycobacterium smegmatis insertion mutant libraries using Tn610 transposon.
Main Results:
- BCG successfully expressed foreign antigens, eliciting specific cellular immune responses against Nef.
- Both cellular and antibody responses were observed against beta-galactosidase.
- Oral immunization with recombinant BCG induced mucosal immunity in mice.
- Transposon mutagenesis yielded representative libraries of Mycobacterium smegmatis mutants.
Conclusions:
- BCG serves as a viable vector for presenting foreign antigens and inducing immune responses, including mucosal immunity.
- Transposon mutagenesis is a promising approach for discovering new tuberculosis vaccine targets.